| | | Small & Midcap Stock Forum Small & Mid Cap Stocks exchange between one and ten dollars, and usually have capitalizations of between $300 million and $10 billion. |  | 
03-10-2010, 09:32 PM
|  | Administrator | | Join Date: Jun 2007
Posts: 107,320
| | EMIS Emisphere Technologies, Inc.
EMIS is going to challenge the old high..Big inverted head and shoulders pattern..
EMIS Chart
Emisphere Technologies, Inc.
240 Cedar Knolls Road
Suite 200
Cedar Knolls, NJ 07927
United States - Map
Phone: 973-532-8000
Fax: 973-532-8121
Web Site: Emisphere - Eligen® Technology
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Drug Delivery
Full Time Employees: 20
BUSINESS SUMMARY
Emisphere Technologies, Inc., a biopharmaceutical company, focuses on the delivery of therapeutic molecules and pharmaceutical compounds using its eligen technology. The eligen technology could be applied to the oral route of administration, as well as the other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal, or transdermal. The companys product pipeline includes Oral Salmon Calcitonin, which is in Phase III clinical trials for the treatment of osteoporosis and osteoarthritis; Oral Recombinant Parathyroid Hormone, which is in Phase I clinical trials for the treatment of osteoporosis; and Oral Heparin that is in Phase III clinical trials, as well as Oral Low Molecular Weight Heparin, which is in Phase I clinical trials for the treatment of cardiovascular diseases. Its products under development also comprise Oral Insulin, which is in Phase II clinical trials, as well as Oral Glucagon-Like Peptides, which is in Phase I clinical trials for the treatment of diabetes; Oral Recombinant Human Growth Hormone that is in Phase I clinical trials for the treatment of growth disorders; and Oral Acyclovir, an anti-viral compound that is in Phase I clinical trials. In addition, the companys product pipeline consists of Oral PYY 3-36, which is in Phase I clinical trials for treating obesity; Oral Cromolyn Sodium that is in Phase I clinical trials for the treatment of asthma/allergies; and Oral Gallium, a preclinical stage product candidate, for oncology treatment. Emisphere Technologies has collaboration agreements with Novartis Pharma AG; Roche; and Genta, Inc. The company was founded in 1985. It was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. The company is headquartered in Cedar Knolls, New Jersey.
| 
03-14-2010, 10:49 AM
|  | Administrator | | Join Date: Jun 2007
Posts: 107,320
| | Re: EMIS Emisphere Technologies, Inc.
EMIS moved right up to the old high. Now we will see if it any more legs. EMIS chart above is current.
| 
03-21-2010, 12:33 PM
|  | Administrator | | Join Date: Jun 2007
Posts: 107,320
| | Re: EMIS Emisphere Technologies, Inc.
Awesome move.. Quote:
Originally Posted by greencat EMIS is going to challenge the old high..Big inverted head and shoulders pattern..
EMIS Chart
Emisphere Technologies, Inc.
240 Cedar Knolls Road
Suite 200
Cedar Knolls, NJ 07927
United States - Map
Phone: 973-532-8000
Fax: 973-532-8121
Web Site: Emisphere - Eligen® Technology
DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Drug Delivery
Full Time Employees: 20
BUSINESS SUMMARY
Emisphere Technologies, Inc., a biopharmaceutical company, focuses on the delivery of therapeutic molecules and pharmaceutical compounds using its ‘eligen’ technology. The eligen technology could be applied to the oral route of administration, as well as the other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal, or transdermal. The company’s product pipeline includes Oral Salmon Calcitonin, which is in Phase III clinical trials for the treatment of osteoporosis and osteoarthritis; Oral Recombinant Parathyroid Hormone, which is in Phase I clinical trials for the treatment of osteoporosis; and Oral Heparin that is in Phase III clinical trials, as well as Oral Low Molecular Weight Heparin, which is in Phase I clinical trials for the treatment of cardiovascular diseases. Its products under development also comprise Oral Insulin, which is in Phase II clinical trials, as well as Oral Glucagon-Like Peptides, which is in Phase I clinical trials for the treatment of diabetes; Oral Recombinant Human Growth Hormone that is in Phase I clinical trials for the treatment of growth disorders; and Oral Acyclovir, an anti-viral compound that is in Phase I clinical trials. In addition, the company’s product pipeline consists of Oral PYY 3-36, which is in Phase I clinical trials for treating obesity; Oral Cromolyn Sodium that is in Phase I clinical trials for the treatment of asthma/allergies; and Oral Gallium, a preclinical stage product candidate, for oncology treatment. Emisphere Technologies has collaboration agreements with Novartis Pharma AG; Roche; and Genta, Inc. The company was founded in 1985. It was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. The company is headquartered in Cedar Knolls, New Jersey. | | 
05-20-2010, 07:16 AM
|  | Super Moderator | | Join Date: Jul 2007
Posts: 895
| | Re: EMIS Emisphere Technologies, Inc.
Emisphere Technologies (OTCBB: EMIS) has made a great climb over the last 6 months. The chart appears that it may be forming a cup and handle continuation pattern. A cup and handle is one of the strongest continuation patterns available. The annotated chart below gives a few things that I am looking at. I also did an annotated video chart on EMIS. It will be available for viewing after processing is completed.
__________________ Learn Pincher Plays and the Basics of Technical Analysis. I've learned a lot from Greencat and CC and a portion of all sales go back to SMC. "Always bear in mind that your own resolution to success is more important than any other one thing." - Abraham Lincoln "The heights by great men reached and kept, were not obtained by sudden flight. But they, while their companions slept, were toiling upward in the night." - Longfellow Full Disclosure | | Thread Tools | | | | Display Modes | Linear Mode |
Posting Rules
| You may not post new threads You may not post replies You may not post attachments You may not edit your posts HTML code is Off | | |
LinkBacks (?)
LinkBack to this Thread: http://www.stockmarketcats.com/f4/emis-emisphere-technologies-inc-64563.html | | Posted By | For | Type | Date | | EMIS | BoardReader | This thread | Refback | 05-06-2010 09:25 AM | All times are GMT -4. The time now is 01:43 PM. |